Table 3.
Secondary outcomes.
| Overall Study Sample | ||||
|---|---|---|---|---|
| Outcome | No. of Studies | No. of Patients | Odds Ratio (95% CI) | Within-Group Heterogeneity (I2) |
| Sample adequacy | 4 | Stent: 598 No stent: 595 |
1.06 (0.67–1.67) p = 0.81 |
0% |
| Diagnostic sensitivity | 5 | Stent: 922 No stent: 1025 |
0.59 (0.44–0.80) p < 0.001 |
14% |
| Outcome | No. of Studies | No. of patients | Mean difference (95% CI) | Within-group heterogeneity (I2) |
| Number of needle passes | 6 | Stent: 794 No stent: 1083 |
−0.09 (−0.30 to 0.11) p = 0.38 |
86% |
| Plastic stent | ||||
| Outcome | No. of Studies | No. of patients | Odds ratio (95% CI) | Within-group heterogeneity (I2) |
| Sample adequacy | 3 | Stent: 298 No stent: 425 |
1.35 (0.71–2.55) p = 0.36 |
0% |
| Diagnostic sensitivity | 4 | Stent: 515 No stent: 920 |
0.68 (0.42–1.10) p = 0.12 |
45% |
| Metal stent | ||||
| Outcome | No. of Studies | No. of patients | Odds ratio (95% CI) | Within-group heterogeneity (I2) |
| Sample adequacy | 2 | Stent: 202 No stent: 351 |
1.10 (0.55–2.20) p = 0.79 |
0% |
| Diagnostic sensitivity | 3 | Stent: 332 No stent: 846 |
0.61 (0.43–0.86) p = 0.006 |
0% |